Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

50 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Platelets and open access - a new era dawns.
Gardiner EE, Halford GM, Harrison P, Parker WAE, Watson SP. Gardiner EE, et al. Among authors: parker wae. Platelets. 2022 Aug 18;33(6):807-808. doi: 10.1080/09537104.2022.2083340. Epub 2022 Jun 8. Platelets. 2022. PMID: 35676756 No abstract available.
Recovery of platelet reactivity following cessation of either aspirin or ticagrelor in patients treated with dual antiplatelet therapy following percutaneous coronary intervention: a GLOBAL LEADERS substudy.
Hennigan BW, Good R, Adamson C, Parker WAE, Martin L, Anderson L, Campbell M, Serruys PW, Storey RF, Oldroyd KG. Hennigan BW, et al. Among authors: parker wae. Platelets. 2022 Jan 2;33(1):141-146. doi: 10.1080/09537104.2020.1863937. Epub 2020 Dec 26. Platelets. 2022. PMID: 33356730
Platelets in 2023: hellos and goodbyes.
Gardiner EE, Halford GM, Parker WAE. Gardiner EE, et al. Among authors: parker wae. Platelets. 2023 Dec;34(1):2204619. doi: 10.1080/09537104.2023.2204619. Platelets. 2023. PMID: 37126352 Free article. No abstract available.
Very-low-dose twice-daily aspirin maintains platelet inhibition and improves haemostasis during dual-antiplatelet therapy for acute coronary syndrome.
Parker WAE, Orme RC, Hanson J, Stokes HM, Bridge CM, Shaw PA, Sumaya W, Thorneycroft K, Petrucci G, Porro B, Judge HM, Ajjan RA, Rocca B, Storey RF. Parker WAE, et al. Platelets. 2019;30(2):148-157. doi: 10.1080/09537104.2019.1572880. Epub 2019 Feb 13. Platelets. 2019. PMID: 30759035 Free PMC article. Clinical Trial.
Prolonged enoxaparin therapy compared with standard-of-care antithrombotic therapy in opiate-treated patients undergoing primary percutaneous coronary intervention.
Sumaya W, Parker WAE, Judge HM, Hall IR, Orme RC, Adam Z, Richardson JD, Rothman AMK, Morgan KP, Gunn JP, Storey RF. Sumaya W, et al. Among authors: parker wae. Platelets. 2021 May 19;32(4):555-559. doi: 10.1080/09537104.2020.1779925. Epub 2020 Jun 16. Platelets. 2021. PMID: 32543247 Free PMC article. Clinical Trial.
Aspirin after PCI: in the twilight of its years?
Parker WAE. Parker WAE. Platelets. 2020 Oct 2;31(7):831-833. doi: 10.1080/09537104.2020.1793927. Epub 2020 Jul 15. Platelets. 2020. PMID: 32669035 No abstract available.
Differential effect of clopidogrel and ticagrelor on leukocyte count in relation to patient characteristics, biomarkers and genotype: a PLATO substudy.
Nelson TA, Parker WAE, Ghukasyan Lakic T, Westerbergh J, James SK, Siegbahn A, Becker RC, Himmelmann A, Wallentin L, Storey RF. Nelson TA, et al. Among authors: parker wae. Platelets. 2022 Apr 3;33(3):425-431. doi: 10.1080/09537104.2021.1934667. Epub 2021 Jun 2. Platelets. 2022. PMID: 34077291 Clinical Trial.
50 results